EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C28H58NO7P |
| Net Charge | 0 |
| Average Mass | 551.746 |
| Monoisotopic Mass | 551.39509 |
| SMILES | CCCCCCCCCCCCCCCCCCOC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(C)=O |
| InChI | InChI=1S/C28H58NO7P/c1-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-23-33-25-28(36-27(2)30)26-35-37(31,32)34-24-22-29(3,4)5/h28H,6-26H2,1-5H3/t28-/m1/s1 |
| InChIKey | ZXCIEWBDUAPBJF-MUUNZHRXSA-N |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Biological Role: | beta-adrenergic antagonist An agent that binds to but does not activate β-adrenergic receptors thereby blocking the actions of endogenous or exogenous β-adrenergic agonists. β-Adrenergic antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches and anxiety. |
| Applications: | hematologic agent Drug that acts on blood and blood-forming organs and those that affect the hemostatic system. vasodilator agent A drug used to cause dilation of the blood vessels. beta-adrenergic antagonist An agent that binds to but does not activate β-adrenergic receptors thereby blocking the actions of endogenous or exogenous β-adrenergic agonists. β-Adrenergic antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches and anxiety. bronchoconstrictor agent A drug which causes a narrowing of the lumen of a bronchus or bronchiole. antihypertensive agent Any drug used in the treatment of acute or chronic vascular hypertension regardless of pharmacological mechanism. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| 2-O-acetyl-1-O-octadecyl-sn-glycero-3-phosphocholine (CHEBI:52450) has role antihypertensive agent (CHEBI:35674) |
| 2-O-acetyl-1-O-octadecyl-sn-glycero-3-phosphocholine (CHEBI:52450) has role bronchoconstrictor agent (CHEBI:50141) |
| 2-O-acetyl-1-O-octadecyl-sn-glycero-3-phosphocholine (CHEBI:52450) has role hematologic agent (CHEBI:50248) |
| 2-O-acetyl-1-O-octadecyl-sn-glycero-3-phosphocholine (CHEBI:52450) has role vasodilator agent (CHEBI:35620) |
| 2-O-acetyl-1-O-octadecyl-sn-glycero-3-phosphocholine (CHEBI:52450) has role β-adrenergic antagonist (CHEBI:35530) |
| 2-O-acetyl-1-O-octadecyl-sn-glycero-3-phosphocholine (CHEBI:52450) is a 2-acetyl-1-alkyl-sn-glycero-3-phosphocholine (CHEBI:36707) |
| IUPAC Names |
|---|
| (2RR)-2-acetoxy-3-(octadecyloxy)propyl 2-(trimethylazaniumyl)ethyl phosphate |
| (2R)-2-acetoxy-3-(octadecyloxy)propyl 2-(trimethylammonio)ethyl phosphate |
| Synonyms | Source |
|---|---|
| platelet activating factor | ChEBI |
| PAF | SUBMITTER |
| PAF-acether | SUBMITTER |
| AGEPC | SUBMITTER |
| acetyl-glyceryl-ether-phosphorylcholine | SUBMITTER |
| 1-O-octadecyl 2-O-acetyl sn-glycero-3-phosphorylcholine | ChemIDplus |
| UniProt Name | Source |
|---|---|
| 1-O-octadecyl-2-acetyl-sn-glycero-3-phosphocholine | UniProt |
| Manual Xrefs | Databases |
|---|---|
| DB02261 | DrugBank |
| LMGP01020094 | LIPID MAPS |
| LMGP01020094 | LIPID MAPS |
| Platelet-activating_factor | Wikipedia |
| Registry Numbers | Sources |
|---|---|
| Beilstein:5364572 | Beilstein |
| Reaxys:5364572 | Reaxys |
| Reaxys:5364572 | Reaxys |
| CAS:74389-69-8 | ChemIDplus |
| CAS:74389-69-8 | ChemIDplus |